Home › Burkitt Lymphoma › Connecticut › Bridgeport
Burkitt Lymphoma clinical trials in Bridgeport, CT
4 studies for Burkitt Lymphoma are looking for participants at sites in and around Bridgeport (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
RecruitingPhase 2
- Stony Brook University Medical Center, Stony Brook · 18 mi away
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
RecruitingPhase 2
- Stony Brook University Medical Center, Stony Brook · 18 mi away
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
RecruitingPhase 2
- Stony Brook University Medical Center, Stony Brook · 18 mi away
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
RecruitingPhase 3
- Stony Brook University Medical Center, Stony Brook · 18 mi away
Burkitt Lymphoma trials in other cities
- Houston, TX21 studies
- Milwaukee, WI16 studies
- Philadelphia, PA16 studies
- New York City, NY14 studies
- Chicago, IL14 studies
- Cincinnati, OH12 studies
- Atlanta, GA12 studies
- Seattle, WA11 studies
- Boston, MA10 studies
- Durham, NC10 studies
- Aurora, CO10 studies
- Los Angeles, CA10 studies
Other studies in Bridgeport
- Breast Cancer21 studies
- Non-Small Cell Lung Cancer14 studies
- Lung Cancer13 studies
- Acute Myeloid Leukemia12 studies
- Cardiovascular Disease9 studies
- Head and Neck Squamous Cell Carcinoma8 studies
- Cancer (all types)8 studies
- Metastatic Cancer7 studies
- Heart Failure7 studies
- Brain Aneurysm6 studies
- Prostate Cancer6 studies
- Multiple Myeloma6 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.